A. Pettinato

Interleukin-2 Patients Treated with Intraarterial Infusion of Recombinant Local Activation of Immune Response in Bladder Cancer

L. Frati, A. Santoni, A. Stoppacciaro, 2006 .

Local activation of immune response in bladder cancer patients treated with intraarterial infusion of recombinant interleukin-2.

A. Stoppacciaro, A. Tubaro, L. Ruco, 1991, Cancer research.

Continuous intra‐arterial administration of recombinant interleukin‐2 in low‐stage bladder cancer. A phase IB study

L. Frati, A. Santoni, A. Stoppacciaro, 1991, Cancer.

Local/regional recombinant interleukin 2 (rIL-2) immunotherapy of tumors. Intra-arterial continuous infusion of rIL-2 in bladder cancer patients: a phase I study.

A. Stoppacciaro, A. Tubaro, L. Ruco, 1990, Annali dell'Istituto superiore di sanita.

Anti-SARS CoV2 antibody testing in healthcare workers: comparison between rapid-cassette tests, ELISA and CLIA methods.

R. Rigolini, P. Giubbilini, M. C. Corsi Romanelli, 2021, Journal of biological regulators and homeostatic agents.